Darren Traub, DO
Cardiovascular Disease · Bethlehem, PANPI 1679602288
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Medtronic at 57.5% of the total. Among cardiovascular disease clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 251 payments — averaging $193.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$28K
- Philips North America LLC$6K
- Abbott$6K
- Boston Scientific$3K
- Medical Device Business Services, Inc.$2K
- Atricure, Inc.$1K
- plus $3K from 13 others
Across 116 payments — averaging $2868.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$318K
- Janssen Research & Development, LLC$15K
What the payments were for
- Consulting fees$8002%
- Speaking & faculty fees$21,96045%
- Travel & lodging$15,95633%
- Food & beverage$9,94920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 117 | $27,984 |
| Philips North America LLC | 5 | $6,034 |
| Abbott | 47 | $5,725 |
| Boston Scientific | 39 | $3,445 |
| Medical Device Business Services, Inc. | 2 | $1,540 |
| Atricure, Inc. | 2 | $1,170 |
| Siemens Medical Solutions USA, Inc. | 9 | $961 |
| Edwards Lifesciences | 11 | $689 |
| Endologix LLC | 2 | $174 |
| Impulse Dynamics (USA) Inc. | 1 | $157 |
| Biosense Webster, Inc. | 2 | $156 |
| ZOLL Respicardia, Inc. | 1 | $150 |
| Boehringer Ingelheim | 1 | $125 |
| Inspire Medical Systems, Inc. | 1 | $125 |
| Shockwave Medical, Inc | 6 | $124 |
| Terumo Medical Corporation | 2 | $39 |
| Biotronik Inc. | 1 | $28 |
| GE HealthCare | 1 | $26 |
| Cook Medical LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$17,259
- Spectranetics Undiv$5,865
- AVEIR$3,586
- AURORA EV-ICD MRI SURESCAN$1,894
- Carto 3 System$1,540
- GENERAL - THERAPIES$1,476
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,170
- Accent Pacemaker$800
- CARDIOBLATE CRYOFLEX$743
- WATCHMAN Access System$722
- ARCTIC FRONT ADVANCE$709
- LINQ II$638
- SAPIEN 3 Ultra RESILIA$328
- OPTIMIZER$314
- PulseSelect$243
- EVERA MRI XT DR SURESCAN$209
- ENSITE$166
- TYRX$151
- remede System$150
- (9124) LM Undivided$147
How this compares
$48,665 in reported general payments places this provider in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 324 | $416,517 |
| XareltoRivaroxaban | 161 | $175,405 |
| MultaqDronedarone Hcl | 20 | $40,036 |
| Dofetilide | 164 | $35,550 |
| Flecainide Acetate | 177 | $7,911 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 23 | $7,383 |
| Metoprolol Succinate | 325 | $5,307 |
| Amiodarone Hcl | 77 | $4,852 |
| Nebivolol Hcl | 99 | $4,807 |
| Diltiazem 12hr ErDiltiazem Hcl | 12 | $3,898 |
| Bisoprolol Fumarate | 96 | $3,853 |
| Propafenone Hcl ErPropafenone Hcl | 13 | $3,259 |
| PradaxaDabigatran Etexilate Mesylate | 13 | $2,513 |
| Digoxin | 51 | $2,439 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 80 | $2,404 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimPradaxa | $125 | $2,51313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Other cardiovascular disease in Bethlehem
- David AllenBethlehem$352K
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Rhian DaviesYork$853K
- Sarang MangalmurtiBryn Mawr$728K
- Sabahat BokhariAllentown$578K
- George GabrielPittsburgh$563K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.